Inflammatory Bowel Diseases: From Bench to Bedside : Proceedings of the Falk Symposium No. 96 (Part IV of the Gastroenterology Symposia 1996) Held in Freiburg-im-Breisgau, Germany, October 30-November 1, 1996T. Andus |
From inside the book
Results 1-3 of 37
Page 313
... nutrition in the treat- ment of active Crohn's disease , and the advantage of elemental compared with a polymeric formulation was not supported . Finally , Messori et al.21 again supported the superiority of steroids over enteral nutrition ...
... nutrition in the treat- ment of active Crohn's disease , and the advantage of elemental compared with a polymeric formulation was not supported . Finally , Messori et al.21 again supported the superiority of steroids over enteral nutrition ...
Page 416
... Nutrition Full Oral Diet Remaining Bowel < 60-80 cm TPN Oral / not Cont Enteral tolerated TPN Nutrition + Drug Therapy Figure 1 Nutrition scheme in short bowel dependent on the remaining length of small bowel during the different phases ...
... Nutrition Full Oral Diet Remaining Bowel < 60-80 cm TPN Oral / not Cont Enteral tolerated TPN Nutrition + Drug Therapy Figure 1 Nutrition scheme in short bowel dependent on the remaining length of small bowel during the different phases ...
Page 418
... nutrition Despite all efforts to optimize modes of enteral nutrition and drug therapy , a sub- stantial number of patients cannot cope with oral or enteral nutrition alone , but require parenteral nutrition at certain intervals or ...
... nutrition Despite all efforts to optimize modes of enteral nutrition and drug therapy , a sub- stantial number of patients cannot cope with oral or enteral nutrition alone , but require parenteral nutrition at certain intervals or ...
Contents
new data | 5 |
Current and future parameters for stratification | 13 |
Genetic and chemical models of inflammatory bowel | 21 |
Copyright | |
44 other sections not shown
Common terms and phrases
acid active Crohn's disease acute adhesion molecules antibody antigens associated azathioprine bacterial budesonide cancer CD4+ T cells chronic Clin clinical colectomy colitis and Crohn's collagen colonic controlled trial corticosteroids Crohn's disease cyclosporine cytokines disease activity dose drugs dysplasia effect elemental diet endoscopic enemas expression fibroblasts fistulae function Gastroenterol Gastroenterology gastrointestinal gene genetic growth factor human IFN-y ileal ileostomy ileum immune Immunol increased induced inflammation inflammatory bowel disease inhibition integrins interleukin intestinal epithelial cells intestinal inflammation lamina propria lesions levels lymphocytes macrophages mast cells measles mediators mesalazine metabolism metronidazole mice mucosal normal oral pathogenesis patients with Crohn's patients with inflammatory patients with ulcerative peptide placebo pouch pouchitis prednisolone proctocolectomy production protein recent receptor recurrence relapse remission resection response risk role short bowel syndrome small bowel small intestine steroid stimulation studies sulphasalazine surgery therapeutic therapy tissue TNF-a treatment tumor necrosis ulcerative colitis